Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1089531 | 0.80 | KDM4E (0.41) | TDP1KDM4EEPHX2ALDH1A1GAA | |
| SCHEMBL13888501 | 0.77 | EPHX2 (0.35) | TDP1KDM4EEPHX2ALDH1A1LMNA | |
| SCHEMBL14694398 | 0.77 | KDM4E (0.35) | TDP1TSHRKDM4EEPHX2ALDH1A1 | |
| SCHEMBL14706712 | 0.77 | KDM4E (0.35) | TDP1TSHRKDM4EEPHX2ALDH1A1 | |
| SCHEMBL4739740 | 0.77 | KDM4E (0.40) | TDP1KDM4EEPHX2ALDH1A1LMNA | |
| SCHEMBL8853008 | 0.77 | KDM4E (0.44) | TDP1TSHRKDM4EEPHX2ALDH1A1 | |
| SCHEMBL8464466 | 0.76 | KDM4E (0.42) | TDP1TSHRKDM4EEPHX2ALDH1A1 | |
| SCHEMBL1087617 | 0.76 | EPHX2 (0.41) | TDP1KDM4EEPHX2ALDH1A1GAA | |
| SCHEMBL9858186 | 0.76 | KDM4E (0.38) | TDP1TSHRKDM4EEPHX2ALDH1A1 | |
| SCHEMBL26935789 | 0.76 | EPHX2 (0.38) | TDP1TSHRKDM4EEPHX2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
| CN-101012314-B | Optical anisotropy thin film and display device containing same | LG CHEMICAL CO., LTD. (KR) | 2011-12-28 | — | — | CN | disclosed |
| CN-100347207-C | Method for polymerizing cycloolefin polymer having polar functional group and electronic device using the polymerized cycloolefin | LG CHEMICAL LTD (KR) | 2007-11-07 | — | — | CN | disclosed |
| CN-101012314-A | Optical anisotropy thin film and display device containing same | LG CHEMICAL LTD (KR) | 2007-08-08 | — | — | CN | disclosed |
| CN-1692131-A | Method for polymerizing cycloolefin polymer having polar functional group and electronic device using the polymerized cycloolefin | LG CHEMICAL LTD (KR) | 2005-11-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CBR1, CBR3, TAS2R1 | TDP1 2948/4885TSHR 1119/4885KDM4E 4643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.